Montelukast Sodium Tablet, Chewable
Product Images NDC 50268-573

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Montelukast Sodium (NDC 50268-573). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avpak, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label 5026857315 Montelukast Sodium 2019 4mg

This is a description of medication in chewable tablet form with the active ingredient Montelukast Sodium. The tablets are 4mg each and are typically prescribed for pediatric patients between the ages of 2-5. The medication is dispensed with a patient leaflet and should be stored at controlled room temperature, protected from moisture and light, and in its original packaging. The dosage should be determined by the accompanying circular, and the patient should keep this and all medication out of the reach of children. The manufacturer is Avkare Inc.*

FDA Label Image

Label 5026857415 Montelukast Sodium 2019 5mg

This is a prescription medicine with the name Montelukast Sodium, which comes in the form of chewable tablets. Each tablet contains 5.2 mg Montelukast Sodium which is equivalent to 5 mg Montelukast. The medicine is generally prescribed to patients between 6-14 years of age. The pack contains 50 tablets (5 X 10) with a circular that shows the usual dosage. The tablets should be stored at 25°C (77°F) with excursions permitted to 15-30°C (50-86°F). The pack also warns to keep this and all drugs away from the reach of children. The drug is manufactured for AVKARE, Inc.*

FDA Label Image

Label 5026857515 Montelukast Sodium 2019 10mg

Montelukast Sodium Tablets are prescription drugs that come in a unit dose of 50 tablets (5X10). The drug is suitable for adults of age 15 and above. Each tablet of the drug comprises Monfelukast Sodium which is equivalent to 10mg of Monfelukast. The user is advised to see the accompanying circular for the usual dosage. The drug must be stored at 26°C (77°F) but excursions permitted to 15-30°C (59-86°F) after protecting it from moisture and light. It is essential to keep the original package of the drug away from children's reach. The manufacturer of the drug is AVKARE, inc., Pulaski, TN 38478.*

FDA Label Image

Figure 1 (Montelukast Sodium Tablets And Chewable Tablets 1)

This is a graph showing the change in height (in centimeters) over time, specifically in relation to different treatments: Montelukast Sodium 5 mg, Beclomethasone 336 mcg, and Placebo. The graph includes data from 120, 119, and 121 individuals, respectively, and spans 56 weeks of treatment. There is also a strange string of characters ("Sohoanwsno") that does not seem to be relevant to the plot.*

FDA Label Image

Chemical Structure (Montelukast Sodium Tablets And Chewable Tablets 2)

FDA Label Image

Figure 2 (Montelukast Sodium Tablets And Chewable Tablets 3)

The text describes a chart or graph presenting the mean percent change from baseline over a period of up to 15 weeks in treatment or washout. The data relates to two treatments, a placebo and a drug called Montelukast Sodium.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.